Jean PILETTE
Ce
document peut être diffusé pour autant qu’il le soit dans
son intégralité et avec le seul souci d’informer.
ALUMINIUM et VACCINS TABLE DES MATIERES
ALUMINIUM : ETAT NATUREL – EXTRACTION – UTILISATION
3
ALUMINIUM : ROLE DANS CERTAINES
PATHOLOGIES 4
ALUMINIUM : VOIES D’ABSORPTION 7
ALUMINIUM : DANS LE SANG 13
ALUMINIUM : ELIMINATION 15
ALUMINIUM ET BARRIERE SANG-CERVEAU 16
ALUMINIUM ET VACCINS 18
EN RESUME 34
CONCLUSIONS 36
ANNEXES 37
BIBLIOGRAPHIE 40
Voici
l'accès à tous les posts du forum sur le sujet
BIBLIOGRAPHIE
1-BURNATOWSKA-HLEDIN
M.A. , KAISER L. , MAYOR G.H.,
«
Aluminum, parathyroid hormone, and osteomalacia. »
Spec.Top.Endocrinol.Metab.
1983 ;5 : 201-226.
2- TZAMALOUKAS
A.H. , AGABA E.I. ,
«
Neurological manifestations of uraemia and chronic dialysis. »
Niger.J.Med.2004
Apr-Jun ; 13 (2) : 98-105.
Department
of Medicine, University of New Mexico School of Medicine, Albuquerque,
New Mexico, USA.
3-ALFREY
A.C. , LEGENDRE G.R., KAEHNYW.D.,
«
The dialysis encephalopathy syndrome. Possible aluminum intoxication. »
N.Engl.J.Med.,
1976 Janv 22 ;294 (4)
: 184-188.
4-Mc
DERMOTT J.R. , SMITH A.I. , WARD M.K. , PARKINSON I.S. , KERR D.N. ,
«
Brain-aluminium concentration in dialysis encephalopathy. »
Lancet.
1978 Apr 29 ; 1 (8070) : 901-904.
5-ROB
P.M., NIEDERSTADT C. , REUSCHE E. ,
«
Dementia in patients undergoing long-term dialysis : aetiology, differential
diagnoses, epidemiology and management. »
CNS
Drugs2001 ; 15 (9) : 691-699.
Nephrologisches
Zentrum am Klinikum Sud, Kalhlhorststrasse 31, D-23552 Lubek, Germany.
6-ACKRILLP.,
DAY J.P. ,
«
Desferrioxamine in the treatment of aluminum overload. »
Clin.
Nephrol.1985 ; 24 Suppl 1 : 94-97.
7-YOKEL
R.A. , ACKRILLP., BURGESS E. , DAY
J.P. , DOMINGO J.L. , FLATEN T.P. ,
SAVORY
J. ,
«
Prevention and treatment of aluminum toxicity including chelation therapy
: status and research needs. »
J.Toxicol.Environ.Health1996
Aug 30 ; 48 (6) : 667-683.
College
of Pharmacy, University of Kentucky Medical Center, Lexington 40536-0082,
USA.
8-CRAPPER
D.R. , KRISHNAN S.S. ,DALTON A.J.
,
«
Brain aluminium distribution in Alzheimer’s disease and experimental neurofibrillary
degeneration. »
Science.1973
;180 : 511-513.
Department
of the Planet Earth, Inc., 701 E Street, Suite 200 , Washington, DC20003,
USA.
9-JANSSON
E.T. ,
«
Aluminum exposure and Alzheimer’s disease. »
J.Alzheimers
Dis.2001 Dec ; 3 (6) : 541-549.
Department
of the Planet Earth, Inc., 701 E Street, SE, Suite 200 , Washington, DC20003,
USA.
10-DARTIGUES
J.F. , GAGNON M. , BARBERGER-GATEAU P. , LETENNEUR L. ,
COMMENGES
D. , SAUVEL C. , MICHEL P. , SALAMON R. ,
«
The Paquid epidemiological program on brain ageing. »
Neuroepidemiology.1992
; 11 Suppl. 1 : 14-18.
INSERM
U330, Université de Bordeaux II, France.
11-MICHEL
P. , COMMENGES D. , DARTIGUES J.F. , GAGNON M. and Paquid Research
Group,
«
Study on the relationship between Alzheimer’s disease and aluminum in drinkingwater
(abstract)
Neurobiol.
Aging.1990 ;11
: 264.
12-CHEN
K.M.,
«
(Disappearance of ALS from Guam : implications for exogenous causes. »)(Japanese)
Rinsho
Shinkeigaku1995 Dec ;35
(12) : 1549-1553.
Department
of Neurology, Guam Memorial Hospital.
13-GAJDUSEKD.C.
andSALAZAR A.M. ,
«
Amyotrophic lateral sclerosis and parkinsonian syndromes in high incidence
among the Auya and Jakai people of West New Guinea. »
Neurology.1982
Feb;32
(2) : 107-126.
14-GARRUTO
R.M. ,GAJDUSEK D.C. , CHEN K.M.
,
«
Amyotrophic lateral sclerosis among Chamorro migrants from Guam. »
Ann.Neurol.1980
Dec ;8 (6) : 612-619.
15-KONAGAYA
M. , KATO T. , SAKAI M. , KURU S. , MATSUOKA Y. , KONAGAYA Y. ,
HASHIZUME
Y. , TABIRA T. ,
«
A clinical and pathological study of a Japanese case of Amyotrophic Lateral
Sclerosis/Parkinsonism-Dementia
Complex with family history. »
J.Neurol.2003
Feb ;250 (2) : 164-170.
Department
of Neurology, Suzuka National hospital, 3-2-1 Kasado, Suzuka,
Mie
513-8501, Japan.
16-PERL
D.P. , GAJDUSEK D.C. , GARRUTO R.M. , YANAGIHARA R.T. , GIBBS C.J.Jr. ,
«
Intraneuronal aluminum accumulation in amyotrophic lateral sclerosis and
Parkinsonism-dementia of Guam. »
Science.1982
Sep. 10;217
(4564) : 1053-1055.
17-GARRUTO
R.M. , SWYT C. , FIORI C.E. , YANAGIHARA R.T.,
GAJDUSEK D.C. ,
«
Intraneuronal deposition of calcium and aluminium in amyotrophic lateral
sclerosis
of
Guam. »
Lancet1985
Dec 14 ;2 (8468) : 1353.
18-PICCARDO
P. , YANAGIHARA R.T. , GARRUTO R.M. , GIBBS C.J.Jr. , GAJDUSEK D.C. ,
«
Histochemical and X-ray microanalytical localization of aluminum in amyotrophic
lateral sclerosis and parkinsonism-dementia of Guam. »
Acta
Neuropathol. (Berl).1988 ;77
(1) : 1-4.
Laboratory
of Central Nervous System Studies, National Institutes of Health, Bethesda,
MD
20892.
19-YASUI
M. , YASE Y. , OTA K. , GARRUTO R.M. ,
«
Aluminum deposition in the central nervous system of patients with amyotrophic
lateral sclerosis from the Kii Peninsula of Japan. »
Neurotoxicology1991
Fall ; 12 (3) 615-620.
Division
of Neurological Diseases, Wakayama Medical College, Japan.
20-REED
D.M. , BRODY J.A. ,
«
Amyotrophic lateral sclerosis and parkinsonism-dementia on Guam, 1945-1972.
I.
Descriptive epidemiology. »
Am.J.Epidemiol.1975
Apr ;101 (4) : 287-301.
21-YANAGIHARA
R.T. , GARRUTO R.M. , GAJDUSEK D.C. ,
«
Epidemiological surveillance of amyotrophic lateral sclerosis and parkinsonism-dementia
in
the Commonwealth of the Northern Mariana Islands. »
Ann.Neurol.1983
Jan ;13 (1) : 79-86.
22-PLATO
C.C. ,GARRUTO R.M. ,FOX
K.M. , GAJDUSEK D.C. ,
«
Amyotrophic lateral sclerosis and parkinsonism-dementia on Guam : a 25-year
prospective
case-control study. »
Am.J.Epidemiol.1986
Oct ;124 (4) : 643-656.
23-OKUMURA
H. ,
«
Epidemiological and clinical patterns of western pacific amyotrophic lateral
sclerosis
(ALS)
in Guam and sporadic ALS in Rochester, Minnesota, U.S.A. and Hokkaido,
Japan :
a
comparative study. »
Hokkaido
University Graduate School of Medicine, Sapporo 060-8638, Japan.
24-GARRUTO
R.M. ,YANAGIHARA R.T.,GAJDUSEK
D.C. ,
«
Disappearance of high-incidence amyotrophic lateral sclerosis and parkinsonism-
dementia
on Guam. »
Neurology.1985
Feb ;35 (2) : 193-198.
25-PLATO
C.C. , GARRUTO R.M. , GALASKO D. , CRAIG U.K. , PLATO M. ,
GAMST
A. , TORRES J.M. , WIEDERHOLT W. ,
«
Amyotrophic lateral sclerosis and parkinsonism-dementia complex of Guam
:
changing
incidence rates during the past 60 years. »
Am.J.Epidemiol.2003
Jan 15 ;157 (2) : 149-157.
Department
of Neurosciences, University of California San Diego School of Medicine,
La
Jolla 92093-0624, USA.
26-GARRUTO
R.M. ,SHANKAR S.K., YANAGIHARA R.T.,SALAZAR
A.M., AMYX H.L. ,
GAJDUSEK
D.C. ,
«
Low-calcium, high-aluminum diet-induced motor neuron pathology in cynomolgus
monkeys.
»
Acta
Neuropathol. (Berl.)1989 ;78
(2) : 210-219.
Laboratory
of Central Nervous System Studies, National Institute of Neurological Disorders
and
Stroke, Bethesda, MD 20892.
27-YASUI
M. , YASE Y. , OTA K. , GARRUTO R.M. ,
«
Evaluation of magnesium, calcium and aluminum metabolism in rats and monkeys
maintained on calcium-deficient diets. »
Neurotoxicology.1991
Fall ; 12 (3) 603-614.
Division
of Neurological Diseases, Wakayama Medical College, Japan.
28-YASE
Y. ,
(«
Amyotrophic lateral sclerosis-causative role of trace elements. »)
(Japanese)
Nippon
Rinsho1996 Jan54
(1) 123-128.
Research
Center of Neurological Diseases, Kansai College of Oriental Medicine.
29-YASUI
M. , OTA K. ,
«
Aluminum decreases the magnesium concentration of spinal cord and trabecular
bone
in
rats fed a low calcium, high aluminum diet. »
J.Neurol.Sci.1998
Apr 15 ;157 (1) : 37-41.
Division
of Neurological Diseases, Wakayama Medical College, Japan.
30-PERL
D.P. ,BRODY A.R. ,
«
Alzheimer’s disease : X-ray spectrometric evidence of aluminum accumulation
in
neurofibrillary tangle-bearing neurons. »
Science1980
Apr 18 ;208 (4441) : 297-299.
31-PERL
D.P. ,
«
Relationship of aluminum to Alzheimer’s disease. »
Environ.Health
Perspect.1985 Nov ;63
: 149-153.
32-PENDLEBURY
W.W. , BEAL M.F. ,KOWALL N.W.andSOLOMON
P.R. ,
«
Results of immunocytochemical, neurochemical, and behavioral studies in
aluminum-induced neurofilamentous degeneration. »
J.Neural.Transm.
Suppl.1987 ;24
: 213-217.
Department
of Pathology, University of Vermont, College of Medicine, Burlington.
33-ZATTA
P., GIORDANO R. , CORAIN B. , BOMBI G.G. ,
«
Alzheimer dementia and the aluminum hypothesis. »
Med.Hypotheses1988
Jun ; 26 (2) : 139-142.
Centro
C.N.R. Emocianine, Padova, Italy.
34-FORBES
W.F. ,AGWANI N. ,
«
A suggested mechanism for aluminum biotoxicity. »
J.Theor.Biol.1994
Nov 21 ;171 (2) : 207-214.
Statitics
Canada, Health Statistics Division, Ottawa, Ontario.
35-YOKEL
R.A. ,
«
The toxicology of aluminum in the brain : a review. »
Neurotoxicology.2000
Oct ;21 (5) : 813-828.
College
of Pharmacy and Graduate Center for Toxicology, University of Kentucky
Medical
Center,
Lexington, USA.
36-SCHMIDT
M.L. , ZHUKAVERA V. , PERL D.P. , SHERIDAN S.K. , SCHUCK T. ,
LEE
V.M. , TROJANOWSKI J.Q. ,
«
Spinal cord neurofibrillary pathology in Alzheimer disease and Guam Parkinsonism-
dementia
complex. »
J.Neuropathol.Exp.Neurol.2001
Nov ;60 (11) : 1075-1086.
Center
for Neurodegenerative Disease Research, University of Pennsylvania,
Philadelphia
19104-4283, USA.
37-SUAREZ-FERNANDEZ
M.B. , SOLDADO A.B., SANZ-MEDEL A., VEGA J.A. ,
NOVELLI
A. , FERNANDEZ-SANCHEZ M.T. ,
«
Aluminum-induced degeneration of astrocytes occurs via apoptosis and results
in
neuronal
death. »
Brain
Res.1999 Jul 24 ;835
(2) : 125-136.
Department
of Biochemistry and Molecular Biology, Faculty of Medicine,
University
of Oviedo, 33071, Oviedo, Spain.
38-THEISS
C. , MELLER K. ,
«
Aluminum impairs gap junctional intercellular communication between astroglial
cells
in
vitro. »
Cell.Tissue
Res.2002 Nov ; 310 (2) : 143-154.
Institut
für anatomie, Abteilung für Cytologie, Medizinische Fakultät,
Ruhr-Universität
Bochum,
Universitätstrase, 150, 44780 Bochum, Germany.
39-DELONCLE
R. , HUGUET F. , FERNANDEZ B. , QUELLARD N. , BABIN P. ,
GUILLARD
O. ,
«
Ultrastructural study of rat hippocampus after chronic administration of
aluminum
L-glutamate
: an acceleration of the aging process ».
Center
for Study and Research on Xenobiotics, UPRES EA 1223, Poitiers University
Hospital,
34, rue du Jardin des Plantes, BP 199, 86005 Cedex, Poitiers, France.
40-OTT
S.M.
«
Aluminum accumulation in individuals with normal renal function. »
Am.J.Kidney
Dis.1985Nov.
;6 (5) : 297-301.
41-ANDRESS
D.L. , KOPP J.B., MALONEY N.A. , COBURN J.W. , SHERRARD D.J.,
«
Early deposition of aluminum in bone in diabetic patients on hemodialysis.
»
N.Engl.J.Med.1987
Feb 5 ;316 (6) : 292-296.
42-MORRIS
C.M. ,CANDY J.M. ,OAKLEY
A.E. , TAYLOR G.A. , MOUNTFORT S. ,
BISHOP
H. ,WARD M.K. , BLOXHAM C.A. ,EDWARDSON
J.A. ,
«
Comparison of the regional distribution of transferrin receptors and aluminium
in
theforebrain
of chronic renal dialysis patients. »
J.Neurol.Sci.1989
Dec ;94 (1-3) : 295-306.
M.R.C.
Neurochemical Pathology Unit, Newcastle upon Tyne, U.K.
43-FERNANDEZ
I , FERNANDEZ J.L. , RODRIGUEZ R. , SANZ-MEDEL A., CANNATA J.B. ,
«
Influence of the degree of saturation of iron stores on the gastrointestinal
absorption ofaluminum. »(Article
in Spanish)
Rev.Esp.Fisiol.1989Mar
;45 (1) : 33-39.
Unidad
de Investigacion, Hospital General de Asturias, Universidad de Oviedo,
Espana.
44-CANNATA
J.B. , GOMEZ ALONSO C. , FERNANDEZ MENENDEZ M.J. ,
FERNANDEZ
SOTO I. , Mc GREGOR S. , MENENDEZ-FRAGA P.,BROCK
J.H. ,
«
Iron uptake in aluminium overload : in vivo and in vitro studies. »
Nephrol.Dial.Transplant.1991
;6 (9) : 637-642.
Bone
and Mineral Research Unit, Hospital General de Asturias, Universidad
deOviedo,Spain.
45-CANNATA
J.B. , OLAIZOLA I.R. , GOMEZ-ALONSO C. , MENENDEZ-FRAGA P. ,
ALONSO-SUAREZ
M. , DIAZ-LOPEZ J.B. ,
«
Serum aluminum transport and aluminum uptake in chronic renal failure :
role of iron and aluminum metabolism. »
Nephron.1993
;65 (1) : 141-146.
Bone
and Mineral Research Unit, Hospital General de Asturias, Universidad de
Oviedo,Spain.
46-GOLUB
M.S. , HAN B. ,KEEN C.L. ,
«
Aluminum uptake and effects on transferrin mediated iron uptake in primary
cultures
of
ratneurons, astrocytes and oligodendrocytes.
»
Neurotoxicology.1999Dec.
;20 (6) : 961-970.
Department
of Internal Medicine, University of California, Davis, 95616, USA.
47-SPENCER
H. , KRAMER L. , NORRIS C. , WIATROWSKI E. ,
«
Effect of aluminium hydroxyde on fluoride metabolism. »
Clin.Pharmacol.Ther.1980
Oct ; 28 (4) : 529-535.
48-AHN
H.W. , FULTON B. , MOXON D. , JEFFERY E.H. ,
«
Interactive effects of fluoride and aluminum uptake and accumulation in
bones of rabbits administered both agents in their drinking water. »
J.Toxicol.Environ.Health1995
Mar ;44 (3) : 337-350.
Institute
for Environmental Studies, University of Illinois, Urbana 61801.
49-SMITH
D.R. , CHANG B.S. ,JOHNSON C.E.,
«
Aluminum hydroxyde : evaluation of two dosage forms and two dosing schedules
inreducing
intestinal phosphate absorption. »
Am.J.Hosp.Pharm.1978
Jan ;35 (1) : 58-61.
50-SPENCER
H. , KRAMER L. , NORRIS C. , OSIS D. ,
«
Effect of small doses of aluminum-containing antacids on calcium and phosphorus
metabolism. »
Am.J.Clin.Nutr.1982
Jul ;36 (1) 32-40.
51-MARTIN
R.B. ,
«
Aluminium speciation in biology. »
Ciba
Found Symp.1992 ; 169 : 5-18.
Chemistry
Department, University of Virgtinia, Charlottesville 22903.
52-MAHIEU
S.T. , NAVONI J. , MILLEN N. , DEL CARMEN CONTINI M. ,
GONZALEZ
M. , ELIAS M.M. ,
«
Effects of aluminum on phosphate metabolism in rats : a possible interaction
with
vitamin
D 3 renal production. »
Arch.Toxicol.2004
Jun 18 (Epub ahead of print)
Fisiologia
Humana, Facultad de bioquimica y Ciencias Biologicas, Universidad Nacional
del
Litoral, Paraje El Pozo, 3000, Santa Fe, Argentina.
53-LEVINE
S.N. , SONNIER G.B. , ABREO K. ,
«
Effect of diabetes mellitus and aluminium toxicity on myocardial calcium
transport. »
Toxicology.1990
Dec 17 ;65 (1-2) : 137-148.
Department
of Medicine, Louisiana State University Medical Center, Shreveport 71130.
54-VAN
DER VOET G.B. , DE WOLFF F.A. ,
«
Intestinal absorption of aluminum : effect of sodium and calcium. »
Arch.Toxicol.1998
;72 (2) : 110-114.
Toxicology
Laboratory, Leiden University Medical Centre, The Netherlands.
55-GANDOLFI
L. , STELLA M.P. ,ZAMBENEDETTI P.
,ZATTA P. ,
«
Aluminum alters intracellular calcium homeostasis in vitro. »
Biochim.Biophys.Acta.1998Apr.
28 ;1406 (3) : 315-320.
Dipartimento
di Scienze Farmaceutiche, Universita di Padova, Italy.
56-WIEGMANN
T.B. , DAY H.D. , PATAK R.V. ,
«
Intestinal absorption and secretion of radioactive vanadium (48VO3-) in
rats and effect of Al(OH)3. »
J.Toxicol.Environ.Health.1982
Augu. ;10 (2) : 233-245.
57-FULTON
B. , JAW S. , JEFFERY E.H. ,
«
Bioavailability of aluminum from drinking water »
Fundam.Appl.Toxicol.1989
Jan ;12 (1) : 144-150.
Division
of Nutritional Sciences,University of Illinois, Urbana 61801.
58-BIRCHALL
J.D. , CHAPPELL J.S. ,
«
The chemistry of aluminum and silicon in relation to Alzheimer’s disease.
»
Clin.Chem.1988
Feb ;34 (2) : 265-267.
Imperial
Chemical Industries Plc, Cheshire, U.K.
59-BIRCHALL
J.D. ,
«
The interrelationship between silicon and aluminium in the biological effects
of aluminium. »
Ciba
Found Symp.1992 ;169
: 50-61.
ICI
plc, Runcorn, Cheshire, U.K.
60-BOHRER
D. , DO NASCIMENTO P.C. , MENDONCA J.K. , POLLI V.G. ,
DE
CARVALHO L.M. ,
«
Interaction of aluminium ions with some amino acids present in human blood.
»
Amino
Acids2004 Aug ;27
(1) : 75-83.
61-FERRETTI
G. , MARCHIONNI C. , BACCHETTI T. , GALEAZZI T. , DOUSSET N. ,
«
Effect of aluminium on lipid peroxidation of human high density lipoproteins.
»
Free
Radic.Res.2003 May ;37
(5) : 515-521.
Institute
of Biochemistry, Faculty of Medicine, University of Ancona, Via Ranieri,
1-60131,
Ancona,
Italy.
62-ZATTA
P. , LAIN E. , CAGNOLINI C. ,
«
Effects of aluminum on activity of krebs cycle enzymes and glutamate dehydrogenase
in
rat
brain homogenate. »
Eur.J.Biochem.2000
May ;267 (10) : 3049-3055.
CNR
Center on Metalloproteins, and Department of PharmacologicalSciences, University
of
Padova,
Italy.
63-TONINELLO
A. , CLARI G. , MANCON M. , TOGNON G. , ZATTA P. ,
«
Aluminum as an inducer of the mitochondrial permeability transition. »
J.Biol.Inorg.Chem.2000
Oct ;5 (5) : 612-623.
Dipartimento
di Chimica Biologica, Universita di Padova, Centro di Studio
delle
Biomembrane del CNR, Italy.
64-RIFAT
S.L. ,EASTWOOD M.R. , Mc LACHLAN
D.R. ,COREY P.N.,
«
Effect of exposure of miners to aluminium powder. »
Lancet.1990
Nov.10 ;336 (8724) : 1162-1165.
Department
of Psychiatry, University of Toronto, Canada.
65-HE
S.C. , QIAO N. , SHENG W. ,
«
Neurobehavioral, autonomic nervous function and lymphocyte subsets among
aluminum
electrolytic
workers. »
Int.J.Immunopathol.Pharmacol.2003
May-Aug ;16 (2) : 139-144.
Department
of Occupational and Environment Health, Peking University, Health Science
Center,
Beijing, P R China.
66-VOISIN
C. , FISEKCI F. , BUCLEZ B. , DIDIER A. , COUSTE B. , BASTIEN F.,
BROCHARD
P. , PAIRON J.C.,
«
Mineralogic analysis of the respiratory tract in aluminium oxide-exposed
workers. »
Eur.Respir.J.1996
Sep ;9 (9) : 1874-1879.
Laboratoire
d’Etude des Particules inhalées, Paris, France.
67-JEDERLINIC
P.J. , ABRAHAM J.L. , CHURG A. , HIMMELSTEIN J.S. , EPLER G.R. ,
GAENSLER
E.A. ,
«
Pulmonary fibrosis in aluminum oxide workers, with pathologic examination
and microanalysis in three of them. »
Am.Rev.Respir.Dis.1990
Nov ;142 (5) : 1179-1184.
Pulmonary
and Critical Care Medicine Division, University of Massachusetts Medical
Center, Worcester 01655.
68-SINCZUK-WALCZAK
H. , SZYMCZAK M. , RAZNIEWSKA G. , MATCZAK W. ,
SZYMCZAK
W. ,
«
Effects of occupational exposure to aluminum on nervous system : clinical
and
electroencephalographic
findings. »
Int.J.Occup.Med.Environ.Health.2003
;16 (4) : 301-310.
Outpatient
Clinic of Occupational Diseases, Nofer Institute of Occupational Medicine,
Lodz,
Poland.
69-PERL
D.P. , GOOD P.F. ,
«
Uptake of aluminium into central nervous system along nasal-olfactory pathways.
»
Lancet.1987
May 2 ;1 (8540) : 1028.
70-TJALVE
H. , HENRIKSSON J. ,
«
Uptake of metals in the brain via olfactory pathways. »
Neurotoxicology.1999
Apr-Jun. ;20 (2-3) : 181-195.
Department
of Pharmacology and Toxicology, Faculty of Veterinary Medicine, Swedish.,
University of Agricultural Sciences, Uppsala, Sweden.
71-ABDER-RAHMAN
H. ,
«
Effect of aluminum phosphide on blood glucose level. »
Vet.Hum.Toxicol.1999
Feb ;41 (1) : 31-32.
Forensic
Medicine and Pathology Department, Faculty of Medicine, University of Jordan,
Amman,
Jordan.
72-SINGH
G.P.,
«
Mortality in acute aluminium phosphide poisoning having hypomagnesaemia
with
and
without ECG changes. »
J.Indian
Med.Assoc.2000 Aug ;98
(8) : 446.
73-SIWACH
S.B. , SINGH H. , JAGDISH, KATYAL V.K. , BHARDWAJ G. ,
«
Cardiac arrhythmias in aluminium phosphide poisoning studied by on continuous
holter
and
cardioscopic monitoring. »
J.Assoc.Physicians
India1998 Jul ;46
(7) : 598-601.
Department
of Medicine, Pt. BDS PGIMS, Rohtak, Haryana, India.
74-ABDER-RAHMAN
H. , BATTAH A.H., IBRAHEEM Y.M. , SHOMAF M.S. , EL-BATAINCH N.,
«
Aluminum phosphide fatalities, new local experience. »
Med.Sci.Law2000
Apr ; 40 (2) : 164-168.
Faculty
of Medicine, University of Jordan, Amman, Jordan.
75-ANGER
F. , PAYSAN F. , BROUSSE F. , LE NORMAND I , DEVELAY P. , GAILLARD Y. ,
BAERT
A. , LE GUEUT M.A. , PEPIN G. , ANGER J.P.,
«
Fatal aluminum phosphide poisoning. »
J.Anal.Toxicol.2000
Mar ;24 (2) : 90-92.
Laboratoire
de Toxicologie Pharmaceutique, U.F.R. des Sciences Médicales
et
Pharmaceutiques, Rennes, France.
76-GRAVES
A.B. , WHITE E. , KOEPSELL T.D. ,REFLER
B.V.,BELL
G.V., LANSONE.B. ,
«
The association between aluminum containing products and Alzheimer’s disease.
»
J.Clin.Epidemiol.199043
: 35-44.
Battelle
Seattle Research Center Seattle, WA 98105.
77-LIONE
A. ,
«
Aluminum toxicology and the aluminum-containing medications. »
Pharmacol.Ther.1985
;29 (2) : 155-285.
78-LIONE
A. ,
«
Aluminum intake from non-precription drugs and sucralfate. »
Gen.Pharmacol.1985
;16 (3) : 223-228.
79-SHOSKES
D.A., RADZINSKI C.A., STRUTHERS N.W., HONEY R.J. ,
«
Aluminum toxicity and death following intravesical alum irrigation in a
patient with
renal
impairment. »
J.Urol.1992
Mar ;147 (3) : 697-699.
Division
of Urology, St. Michael’s Hospital, University of toronto, Ontario, Canada.
80-PHELPS
K.R. , NAYLOR K. , BRIEN T.P. , WILBUR H. , HAQQIE S.S. ,
«
Encephalopathy after bladder irrigation with alum : case report and literature
review. »
Am.J.Med.Sci.1999
Se ;318 (3) : 181-185.
Medical,
Laboratory Medicine, and Surgical Services, Stratton Department of
Veterans
Affairs Medical Center, and Albany Medical College, New York 12208, USA.
81-ZAFFE
D. , BERTOLDI C. , CONSOLO U. ,
«
Accumulation of aluminium in lamellar bone after implantation of titanium
plates,
Ti-6Al-4V
screws, hydroxyapatite granules. »
Biomaterials2004
Aug ; 25 (17) : 3837-3844.
82-PENNINGTON
J.A. ,
«
Aluminium content of foods and diets. »
Food
Addit.Contam.1988 Apr-Jun ;5
(2) : 161-232.
Center
for Food Safety and Applied Nutrition, Food and Drug Administration, Washington,
DC.
83-WONG
M.H. , FUNG K.F. , CARR H.P. ,
«
Aluminium and fluoride contents of tea, with emphasis on brick tea and
their
health
implications. »
Toxicol.Lett.2003
Jan 31 ;137 (1-2) : 111-120.
Department
of Biology, Institute for natural Resources and Environmental Management,
Hong
Kong Baptist University, Kowloon, Hong Kong.
84-HAYACIBARA
M.F. , QUEIROZ C.S. , TABCHOURY C.P. , CURY J.A. ,
«
Fluoride and aluminum in teas and tea-based beverages. »
Rev.Saude
Publica.2004 Feb ;38
(1) : 100-105.
Departamento
de Ciencias Fisiologicas, Faculdade de Odontologia de Piracicaba,
Universidade
Estadual de Campinas, Piracicaba, SP, Brazil.
85-FUNG
K.F. , ZHANG Z.Q. , WONG J.W. , WONG M.H. ,
«
Aluminium and fluoride concentrations of three tea varieties growing at
Lantau
Island,
Hong Kong. »
Environ.Geochem.Health2003
Jun ;25 (2) : 219-232.
Institute
for natural Resources and Environmental Management, Department of Biology,
224
Waterloo Road, Hong Kong Baptist University, Kowloon Tong, Hong Kong,
People’s
Republic of China.
86-SHU
W.S. , ZHANG Z.Q. , LAN C.Y. , WONG M.H. ,
«
Fluoride and aluminium concentrations of tea plants and tea products from
Sichuan
Province, PR China. »
Chemosphere2003
Sep ;52 (9) : 1475-1482.
State
Key Laboratory for Bio-contol, School of Life Sciences, Zhongshan University,
Guangzhou
510275, People’s Republic of China.
87-KOCH
K.R. , POUGNET M.A., de VILLIERS S. , MONTEAGUDO F. ,
«
Increased urinary excretion of Al after drinking tea. »
Nature1988
May 12 ;333 (6169) : 122.
88-PENNINGTON
J.A. , SCHOEN S.A.,
«
Estimates of dietary exposure to aluminium ».
Food
Addit.Contam.1995 jan-Feb ;12
(1) : 119-128.
Food
and Drug Administration, Center for Food Safety and Applied Nutrition,
Washington,
DC
20204, USA.
89-WANG
J. ,
(«Current
researches on biological effect of aluminum. »)(Chinese)
Wei
Sheng Yan Jiu2002 Aug ;31
(4) : 320-322.
College
of Public Health, Fudan University, Shanghai 200032, China.
90-SANTE
CANADA, Sous-comité provincial sur l’eau potable,
«
L’aluminium dans l’eau potable. »
Document
pour consultation publique. Décembre 1996.
91-Organisation
mondiale de la santé (OMS)
«
Guidelines for Drinking-Water Quality, 2nd edition, addendum
to volume 1-Recommandations, »
WHO.
, Geneva, 1998.
92-ALLAIN
P. , MAURAS Y. , KRARI N. , DUCHIER J. , COURNOT A. , LARCHEVEQUE J. ,
«
Plasma and urine aluminium concentrations in healthy subjects after administration
of sucralfate. »
Br.J.Clin.Pharmacol.
1990 Apr ;29 (4) : 391-395.
93-HARAM
E.M. , WEBERG R. , BERSTAD A. ,
«
Urinary excretion of aluminium after ingestion of scralfate and a aluminium-containing
antacid in man. »
Scan.J.Gastroenterol.1987
Jun ;22 (5) 615-618.
94-WINTERBERG
B. , BERTRAM H. , ROLF N. , ROEDIG M. , KISTERS K. , REMMERS S. ,
SPIEKER
C. , ZUMKLEY H. ,
«
Differences in plasma and tissue aluminum concentrations due to different
aluminum-containing drugs in patients with renal insufficiency and with
normal renal function. »
J.Trace
Elem.Electrolytes Health Dis.1987
Dec ;1 (2) 69-72.
Medizinische
Poliklinik, Universitat Munster, Rep. Of Germany.
95-LIONE
A. , ALLEN P.V. , SMITH J.C. ,
«
Aluminium coffee percolators as a source of dietary aluminium. »
Food
Chem.Toxicol.1984 Apr ;22
(4) : 265-268.
96-FROMENT
D.P. , MOLITORIS B.A. , BUDDINGTON B. , MILLER N. , ALFREY A.C.,
«
Site and mechanism of enhanced gastrointestinal absorption of aluminum
by citrate. »
Kidney
Int.1989 Dec ;36
(6) : 978-984.
Department
of Medicine, Veterans Administration Medical Center, Denver, Colorado
97-REIBER
S. , KUKULL W., STANDISH-LEE P. ,
«
Drinking water aluminum and bioavailability. »
J.Am.Water
Works Assoc.1995 ;88
: 86-99.
98-DOMINGO
J.L. , GOMEZ M. , LLOBET J.M., CORBELLA J. ,
«
Influence of some dietary constituents on aluminum absorption and retention
in rats. »
Kidney
Int.1991 Apr ;39
(4) : 598-601.
Laboratory
of Toxicology and Biochemistry, School of Medicine, University of Barcelona.
99-DOMINGO
J.L. , GOMEZ M. , LLOBET J.M., CORBELLA J. ,
«
Effect of various dietary constituents on gastrointestinal absorption of
aluminum from drinking water and diet. »
Res.Commun.Chem.Pathol.Pharmacol.1993
Mar ;79 (3) : 377-380.
Laboratory
of Toxicology and Biochemistry, School of Medicine, University of Barcelona.
100-SLANINA
P. , FALKEBORN Y. , FRECH W. , CEDERGREN A. ,
Aluminium
concentrations in the brain and bone of rats fed citric acid, aluminium
citrate
oraluminium
hydroxyde. »
Food
Chem.Toxicol.1984 May ;22
(5) : 391-397.
101-SLANINA
P. , FRECH W. , EKSTROM L.G. , LOOF L. , SLORACH S. , CEDERGREN A. ,
«
Dietary citric acid enhances absorption of aluminum in antacids. »
Clin.Chem.1986
Mar ;32 (3) : 539-541.
102-KIRSCHBAUM
B.B. , SCHOOLWERTH A.C. ,
Acute
aluminium toxicity associated with oral citrate and aluminum-containing
antacids. »
Am.J.Med.Sci.1989
Jan ;297 (1) : 9-11.
Department
of Medicine, Medical College of Virginia, Richmond 23298-0160.
103-PRIEST
N.D. , TALBOT R.J. , AUSTIN J.G. , DAY J.P. , KING S.J. , FIFIELD K. ,
CRESSWELL
R.G. ,
«
The bioavailability of 26Al-labelled aluminium citrate and aluminium hydroxyde
involunteers.
»
Biometals1996
Jul ;9 (3) : 221-228.
AEA
Technology, Harwell, Oxfordshire U.K.
104-DOMINGO
J.L. , GOMEZ M. , LLOBET J.M. , RICHARD C.
«
Effect of ascorbic acid on gastrointestinal aluminium absorption. »
Lancet1991
Dec 7 ;338 (8780) : 1467.
105-VENTURINI-SORIANO
M. , BERTHON G. ,
«
Aluminum speciation studies in biological fluids. Part 7. A quantitative
investigation of
aluminum
(III)-malate complex equilibria and their potential implications for aluminum
metabolism
and toxicity. »
J.Inorg.Biochem.2001
Jun ;85 (2-3) : 143-154.
Equipe
de Chimie Bioinorganique Médicale, ICMPS-CNRS FR 1744, Université
Paul
Sabatier,
118, route de Narbonne (Bat. 3SC), 31062 Toulouse, France.
106-WEBERG
R., BERSTAD A. ,
«
Gastrointestinal absorption of aluminium from single doses of aluminium
containingantacids.
»
Eur.J.Clin.Invest.1986
Oct ;16 (5) : 428-432.
107-MARTIN
R.B.,
«
The chemistry of aluminum as related to biology and medicine ; »
Clin.Chem.1986
Oct ;32 (10) 1797-1806.
108-WICKLUND
G. , SPAREN A. , DANIELSSON L.G. , HAEGGLAND G.andJORHEM
L. ,
«
Bioavailability of labile aluminium in acidic drinking water ; a study
in the rat. »
Food
Chem.Toxicol.1995 May ;33
(5) :403-408.
Swedish
National Food Administration, Uppsala.
109-
EDWARDSON J.A. , MOORE P.B. , FERRIER I.N. , LILLEY J.S. , NEWTON G.W.
,
BARKER
J. , TEMPLAR J. , DAY J.P. ,
«
Effect of silicon on gastrointestinal absorption of aluminium. »
Lancet1993
Jul 31 ;342 (7) : 211-212.
MRC
Neurochemical Pathology Unit, Newcastle General Hospit(al, Newcastle upon
Tyne,
U.K.
110-DAY
J.P. , BARKER J. , EVANS L.J.A. , PERKS J. , SEABRIGHT P.J. , ACKRILL P.
,
LILLEY
J.S. , DRUMM P.V.andNEWTON
G.V.A. ,
«
Aluminum absorption studied by Al-26 tracer. »
Lancet.1991
Jun 1 ;337 (8753) : 1345.
111-WILLS
M.R.andSAVORY
J. ,
«
Water content of aluminum, dialysis dementia, and osteomalacia. »
Environ.Health
Perspect.1985 Nov ;63
: 141-147.
112-WILLS
M.R.andSAVORY
J. ,
«
Aluminum and chronic renal failure : sources, absorption, transport, and
toxicity. »
Crit.Rev.Clin.Lab.Sci.1989
;27 (1) 59-107.
Department
of Pathology and Internal Medicine, University of Virginia Health
Sciences
Center, Charlottesville.
113-
ITTEL T.H. , GLADZIWA U. , MUCK W., SIEBERTH H.G. ,
«
Hyperaluminaemia in critically ill patients : role of antacid therapy and
impaired
renalfunction.
»
Eur.J.Clin.Invest.1991
Feb;21
(1) : 96-102.
Department
of Internal Medicine II, R.W.T.H., Aachen FRG.
114-ALFREY
A.C.,
«
Aluminum toxicity in patients with chronic renal failure. »
Ther.Drug
Monit.1993 Dec ;15
(6) : 593-597.
Renal
Section, Denver Veterans Administration Hospital, Colorado 80220.
115-ITTEL
T.H., STEINHAUSEN C. , KISLINGER G., KINZEL S. , NOLTE E. ,
SIEBERTH
H.G. ,
«
Ultrasensitive analysis of the intestinal absorption and compatmentalization
of
aluminiumin
uraemic rats : a 26Al tracer study employing accelerator
massspectrometry.
»
Nephrol.Dial.Transplant.1997
Jul ;12 (7) : 1369-1375.
Department
of Internal Medicine II, R.W.T.H., Aachen,Germany.
116-MAGNUSSON
M. , MAGNUSSON K.E. , SUNDQVIST T.andDENNEBERG
T. ,
«
Impaired intestinal barrier function measured by differently sized polyethylene
glycols
inpatients
with chronic renal failure. »
Gut1991
;32 (7) : 754-759.
117-MOORE
P.B., DAY J.P. , TAYLOR G.A. , FERRIER I.N. , FIFIELD L.K. ,
EDWARDSON
J.A.,
«
Absorption of aluminium-26 in Alzheimer’s disease, measured using accelerator
mass
spectrometry. »
Dement.Geriatr.Cogn.Disord.2000
Mar-Apr ;11 (2) : 66-69.
MRC
Neurochemical Pathology Unit, Newcastle General Hospit(al, Newcastle upon
Tyne,
U.K.
118-MOORE
P.B., EDWARDSON J.A., FERRIER I.N. , TAYLOR G.A. , LETT D., TYRER S.P.,
DAY
J.P. , KING S.J. , LILLEY J.S. ,
«
Gastrointestinal absorption of aluminum is increased in Down’s syndrome.
»
Biol.
Psychiatry1997 Feb 15 ;41
(4) : 488-492.
Department
of Psychiatry, South Tyneside District General Hospital, South Shields,
U.K.
119-GROSSMAN
A. , KUKULL W.A. , JINNEMAN J.C. , BIRD T.D. , VILLACRES E.C. ,
LARSON
E.B. , RABINOVITCH P.S. ,
«
Intracellular calcium response is reduced in CD4+ lymphocytes in Alzheimer’s
disease
and
in older persons with Down’s syndrome. »
Neurobiol.Aging1993
Mar-Apr ;14 (2) : 177-185.
Department
of Pathology, University of Washington, Seattle 98195.
120-GOLUB
M.S. , DOMINGO J.L. ,
«
What we know and what we need to know about developmental aluminum toxicity.
»
J.Toxicol.Environ.Health1996
Aug 30 ;48 (6) : 585-597.
Department
of Internal Medicine, University of California, Davis 95616, USA.
121-SIMMER
K. , FUDGE A. , TEUBNER J. , JAMES S.L. ,
«
Aluminum concentrations in infant formulae. »
J.Paediatr.Child
Health1990 Feb ;26
(1) : 9-11.
Department
of Paediatrics, Flinders Medical Centre, Australia.
122-NAVARRO-BLASCO
I. , ALVAREZ-GALINDO J.I. ,
«
Aluminium content of Spanish infant formula. »
Food
Addit.Contam.2003 May ;20
(5) : 470-481.
Department
of Chemistry, Faculty of Sciences, University of Navarra, Pamplona, Spain.
123-CHELID
F. , FUDGE A. , TEUBNER J. , JAMES S.L. , SIMMER K. ,
«
Aluminium absorption in infancy. »
J.Paediatr.Child
Health1991 Jun ;27
(3) : 164-166.
Department
of Paediatrics, Flinders Medical Centre, Bedford Park, South Australia.
124-BOZYNSKI
M.E. , SEDMAN A.B. , NAGLIE R.A. , WRIGHT E.J. ,
«
Serial plasma and urinary aluminum levels and tissue loading in preterm
twins. »
J.Parenter.Enteral
Nutr.1989 Jul-Aug ;13
(4) : 428-431.
University
of Michigan Medical Center, Department of Pediatrics, Ann Arbor.
125-BISHOP
N.J. , MORLEY R. , DAY J.P. , LUCAS A. ,
«
Aluminum neurotoxicity in preterm infants receiving intravenous-feeding
solutions. »
N.Engl.J.Med.1997
May 29 ;336 (22) : 1557-1561.
Medical
Research Council (MRC) Dunn Nutrition Unit, Cambridge, U.K.
126-ADVENIER
E. , LANDRY C. , COLOMB V. , COGNON C. , PRADEAU D. , FLORENT M. ,
GOULET
O. , RICOUR C. , CORRIOL O. ,
«
Aluminum contamination of parenteral nutrition and aluminum loading in
children on
long-term
parenteral nutrition. »
J.Pediatr.Gastroenterol.Nutr.2003
Apr ;36 (4) : 448-453.
127-MEIRI
H. , BANIN E. , ROLL M. ,
«
Aluminum ingestion—is it related to dementia ? »
Rev.Environ.Health1991
Oct-Dec ;9 (4) 191-205.
Department
of Physiology, Hebrew University-Hadassah Medical School, Jerusalem,
Israel.
128-ALTMANN
P. , AL-SALIHI F. , BUTTER K. , CUTLER P. , BLAIR J. , LEEMING R. ,
CUNNINGHAM
J., MARSH F. ,
«
Serum aluminum levels and erythrocyte dihydropteridine reductase activity
in patients
onhemodialysis.
»
N.Engl.J.Med.1987
Jul 9;317
(2) : 80-84.
129-BARTON
H.J. , ZACHWIEJA Z. , FOLTA M. , JANUSZ-GRZYBOWSKA E. ,
STOMPOR
T. , SULOWICZ W. , BRZEZICKA M. ,
(«
Pilot study of aluminum plasma level in healthy subjects in Poland. »)
(Polish)
Przegl.Lek.2003
;60 Suppl 6 : 111-114.
Zaklad
Bromatologii, Collegium Medicum, Uniwersytet Jagiellonski, Krakow.
130-GARNIER
R.,
«
Consultations médicales : Neurotoxicité de l’aluminium. »
Le
Concours Médical 22 février 1997 ;119
(7) : 474-475.
131-MARTIN
R.B. ,
«
Citrate binding of Al3+ and Fe3+. »
J.Inorg.Biochem.1986
Oct-Nov ;28 (2-3) : 181-187.
132-MARTIN
R.B. , SAVORY J. , BROWN S. ,BERTHOLF
R.L. , WILLS M.R. ,
«
Transferrin binding of Al3+ and Fe3+. »
Clin.Chem.1987
Mar ;33 (3) : 405-407.
133-FATEMI
S.J.A. , KADIR F.H.A. , MOORE G.R. ,
«
Aluminum transport in blood serum. »
Biochem.J.1991
Dec 1 ; 280 (Pt2) : 527-532 ;280
: 527-532.
Centre
for Metalloprotein Spectroscopy and Biology, School of chemical Sciences,
University
of East Anglia, Norwich, U.K.
134-MAHIEU
S. , DEL CARMEN CONTINI M. , GONZALEZ M. , MILLEN N. , ELIAS M.M. ,
«
Aluminum toxicity. Hematological effects. »
Toxicol.Lett.2000
Jan 5 ;111 (3) : 235-242.
Catedra
de Fisiologia Humana, Facultad de Bioquimica y de Ciencas Biologicas,
Universidad
Nacional del Litoral, Ciudad Universitaria, Santa Fe, Argentina.
135-GONZALEZ-REVALDERIA
J. , CASARES M. , DE PAULA M. , PASCUAL T. , GINER V. ,
MIRAVALLES
E. ,
«
Biochemical and hematological changes in low-level aluminum intoxication.
»
Clin.Chem.Lab.Med.2000
Mar ;38 (3) : 221-225.
136-SUWALSKY
M. , UNGERER B. , VILLENA F. , NORRIS B. , CARDENAS H. , ZATTA P. ,
«
Effects of AlCl3 on toad skin, human erythrocytes, and model cell membranes.
»
Brain
Res.Bull.2001 May 15 ;55
(2) : 205-210.
Faculty
of Chemical Sciences, University of Concepcion, Concepcion, Chile.
137-VITTORI
D. , NESSE A. , PEREZ G. , GARBOSSA G. ,
«
Morphologic and functional alterations of erythroid cells induced by long-term
ingestion
of
aluminium. »
J.Inorg.Biochem.1999
Aug 30 ;76 (2) : 113-120.
Departamento
de Quimica Biologica, Facultad de Ciencias Exactas y Naturales,
Universitad
de Buenos Aires, Argentina.
138-ALFREY
A.C. ,
«
Gastrointestinal absorption of aluminium. »
Clin.Nephrol.1985
;24Suppl.1
: 84-87.
139-PARRY
R. , PLOWMAN D. , DELVES H.T. , ROBERTS N.B. , BIRCHALL J.D. ,
BELLIA
J.P. , DAVENPORT A. , AHMAD R. , FAHAL I. , ALTMANN P. ,
«
Silicon and aluminium interactions in haemodialysis patients. »
Nephrol.Dial.Transplant.1998
Jul ;13 (7) : 1759-1762.
Wessex
Renal & Transplant Unit, St Mary’s Hospital, Portsmouth, U.K.
140-BELLIA
J.P. , BIRCHALL J.D. , ROBERTS N.B. ,
«
The role of silicic acid in the renal excretion of aluminium. »
Ann.Clin.Lab.Sci.1996
May-Jun ;26 (3) : 227-233.
Clinical
Chemistry Department, Royal Liverpool University Hospital, U.K.
141-BANKS
W.A. , KASTIN A.J. ,
«
Aluminum alters the permeability of the blood-brain barrier to some non-peptides.
»
Neuropharmacology1985
May ;24 (5) : 407-412.
142-BANKS
W.A. , KASTIN A.J. , FASOLD M.B.
«
Differential effect of aluminum on the blood-brain barrier transport of
peptides,
technetium
and albumin. »
J.Pharmacol.Exp.Ther.1988
Feb ;244 (2) : 579-585.
Veterans
Administration Medical Center, New Orleans, Louisiana.
143-ZHENG
W. ,
«
Neurotoxicity of the brain barrier system : new implications. »
J.Toxicol.Clin.Toxicol.2001
;39 (7) : 711-719.
College
of Physicians and Surgeons, Columbia University, New york, New York 10032,
USA.
144-KUCUK
M. , KALAYCIR.B. , CEVIK A. , ELMAS
I. , KAYA M. ,
«
Effect of aluminum on the blood-brain barrier permeability in acute and
chronically
hyperglycemic
rats. »
Biol.Trace
Elem.Res.2001 May ;80
(2) : 181-189.
Department
of Physiology of Istanbul Medical Faculty, Institute for experimental Medicine
and
Research, Istanbul University, Turkey.
145-BANKSW.A.
, KASTINA.J. ,
«
Aluminum-induced neurotoxicity : alterations in membrane function at the
blood-brain
barrier. »
Neurosci.Biobehav.Rev.1989
Spring ;13 (1) : 47-53.
Veterans
Administration Medical Center, New Orleans, Louisiana.
146-TUNKEL
A.R. , ROSSER S.W. , HANSEN E.J. , SCHELD W.M. ,
«
Blood-brain barrier alterations in bacterial meningitis : development of
an in vitro model and observations on the effects of lipopolysaccharide.
»
In
Vitro Cell Dev.Biol.1991 Feb ;27A
(2) : 113-120.
Department
of Internal Medicine, University of Virginia School of Medicine, Charlottesville.
147-
SOKRAB T.E. , KALIMO H. , JOHANSSON B.B. ,
«
Endogenous serum albumin content in brain after short-lasting epileptic
seizures. »
Brain
Res.1989 Jun 12 ;489
(2) : 231-236.
Department
of Neurology, University hospital, Lund, Sweden.
148-SOKRAB
T.E. , JOHANSSON B.B. , KALIMO H. , OLSSON Y. ,
«
A transient hypertensive opening of the blood-brain barrier can lead to
brain damage. Extravasation of serum proteins and cellular changes in rats
subjected to aortic compression. »
Acta
Neuropatholol. (Berl)1988 ;75
(6) : 557-565.
Department
of neurology, University of Lund, Sweden.
149-SOKRAB
T.E. , JOHANSSON B.B. , TENGVAR C. , KALIMO H. , OLSSON Y. ,
«
Adrenaline-induced hypertension : morphological consequences of the blood-brain
barrier disturbance. »
Acta
Neurol.Scand.1988 May ;77
(5) : 387-396.
Department
of neurology, University of Lund, Sweden.
150-
OSCAR K.J., HAWKINS T.D. ,
«
Microwvave alteration of the blood-brain barrier system of rats. »
Brain
Res.1977 May 6 ;126
(2) : 281-293.
151-WILLIAMS
W.M. , PLATNER J. , MICHAELSON S.M. ,
«
Effect of 2.450 MHz microwave energy on the blood-brain barrier to hydrophilic
molecules. C. Effect on the permeability to (14C)sucrose. »
Brain
Res. 1984 May ;319 (2) : 183-190.
152-SCHIRMACHER
A. , WINTER S. , FISCHER S. , GOEKE J. , GALLA H.J. ,
KULLNICK
U. , RINGELSTEIN E.B. STOGBAUER F. ,
«
Electromagnetic fields (1,8 GHz) increase the permeability to sucrose of
the blood-brain barrier in vitro. »
Bioelectromagnetics2000
Jul ;21 (5) : 338-345.
Klinik
und Poliklinik für Neurologie, Universität Munster, Germany.
153-SALFORD
L.G. , BRUN A. , STURESSON K. , EBERHARDT J.L. , PERSSON B.R. ,
«
Permeability of the blood-brain barrier induced by 915 MHz electromagnetic
radiation, continuous wave and modulated at 8, 16, 50, and 200 Hz. »
Microsc.Res.Tech.1994
Apr 15 ;27 (6) : 535-542.
Department
of Neurosurgery , Lund University , Sweden.
154-FINNIE
J.V. , BLUMBERGS P.C. , MANAVIS J. , UTTERIDGE T.D. , GEBSKI V. ,
SWIFT
J.G. , VERNON-ROBERTS B. , KUCHEL T.R. ,
«
Effect of global system for mobile communication (gsm)-like radiofrequency
fields on vascular permeability in mouse brain. »
Pathology2001
Aug. ;33 (3) : 338-340.
Veterinary
Services Division, Institute of Medical and Veterinary Science, Adelaide,
SA, Australia.
155-SALFORD
L.G. , BRUN A.E. ,EBERHARDT J.L.
, MALMGREN L. ,PERSSON B.R. ,
«
Nerve cell damage in mammalian brain after exposure to microwaves from
GSM mobile phones.
Environ.Health
Perspect.2003 Jun ;111
(7) : 881-883.
Department
of Neurosurgery, Lund University, The Rausing Laboratory and Lund University
hospital, Lund, Sweden.
156-HASSEL
B. , IVERSEN E.G. , FONNUM F. ,
«
Neurotoxicity of albumin in vivo »
Neurosci.Lett.1994
Feb 14 ;167 (1-2) : 29-32.
157-SALFORD
L.G., PERSSON B. , MALMGREN L. , BRUN A. ,
«
Téléphonie mobile et barrière sang-cerveau »
Communication
faite au colloque organisé le 29 juin 2000 par ECOLO, le CEFE et
le Groupe des Verts au parlement européen / Alliance libre européenne.
Actes
du colloque repris dans le livre sur la « Téléphonie
mobile. Effets potentiels sur la santé des ondes électromagnétiques
de haute fréquence ».
Editions
Marco Pietteur 2001. ISBN 2-87211-055-0.
158-HUBER
R. , GRAF T. , COTE K.A. , WITTMANN L. , GALLMANN E. ,
MATTER
D. , SCHUDERER J. , KUSTER N. , BORBELY A.A. , ACHERMANN P. ,
«
Exposure to pulsed high-frequency electromagnetic field during waking affects
human sleep EEG. »
Neuroreport.2000
Oct 20 ;11 (15) : 3321-3325.
Institute
of Pharmacology and Toxicology, University of Zurich, Switzerland.
159-HUBER
R. , SCHUDERER J. , GRAF T. , JUTZ K. , BORBELY A.A. , KUSTER N. ,
ACHERMANN
P. ,
«
Radiofrequency electromagnetic field exposure in humans : Estimation of
SAR distribution in the brain, effects on sleep and heart rate. »
Bioelectromagnetics2003
May ; 24 (4) : 262-276.
Institute
of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland.
160-HEIMENDINGER
J.
«
(Mixed longitudinal measurements of body length, weight, superior segment,
thorax
circumference and head circumference in 1-24-month-old infants.) »
Helv.Paediatr.Acta1964
Nov ;19 : 406-436.German.
161-HEIMENDINGER
J.
«
(Results of a survey of body measurements of 5000 Basel children 2-18 years
of age.) »
Helv.Paediatr.Acta1964
Nov ;19 :Suppl.13
: 1-131.German.
162-
LOW J.A., KERR N.D., COCHON A.R.,
«
Plasma and blood volume of normal newborn infant and patterns of adjustment
in
initial24 hours of the neonatal
period. »
Am.J.Obstet.Gynecol.1963
Aug 1 ;86 : 886-892.
163-OSGOOD
E.E.,
«
Development and growth of hematopoietic tissues ; with a clinically practical
method
ofgrowth
analysis. »
Pediatrics1955
Jun ;15 (6) : 733-751.
164-SAMET
P., FRITTS H.W. Jr., FISHMAN A.P., COURNAND A.,
«
The blood volume in heart disease. »
Medicine
(Baltimore)1957 May ;36
(2) : 211-235.
165-GHERARDI
R.K., CHERIN P. ,
«
Une nouvelle maladie musculaire : la myofasciite à macrophages.
»
Médecine/Sciences1998
;14 (11) : 1272.
166-GHERARDI
R.K., COQUET M., CHERIN P. , AUTHIER F.J. , LAFORET P. , BELEC L. ,
FIGARELLA-BRANGER
D. , MUSSINI J.M., PELLISSIER J.F. , FARDEAU M. ,
«
Macrophagic myofasciitis : an emerging entity. Groupe d’Etudes et Recherche
sur les
Maladies
Musculaires Acquises et Dysimmunitaires (GERMMAD) de l’Association
Française
contre les Myopathies (AFM). »
Lancet1998
Aug 1 ;352 (9125) : 347-352.
Université
Paris XII-Val de Marne, Département de Pathologie, Hôpital
Henri Mondor,
Creteil,France.
167-CHERIN
P. , LAFORET P. , GHERARDI R.K., AUTHIER F.J. , COQUET M.,
MAISONOBE
T. , MUSSINI J.M., PELLISSIER J.F. , HERSON S. , et le Groupe d’Etudes
et
de recherche sur les maladies musculaires acquises et dysimmunitaires (GERMMAD)
de
l’Association française contre les myopathies (AFM) ,
«
La myofasciite à macrophages : description, hypothèses étiopathogéniques.
»
Rev.Med.Int.1999
Jun ;20 (6) 483-489.
168-CHERIN
P. , LAFORET P. , GHERARDI R.K., AUTHIER F.J. , MAISONOBE T. ,
COQUET
M., , MUSSINI J.M., PELLISSIER J.F. , EYMARD B.,HERSON
S.et
le
Groupe d’Etudes et Recherche sur les Maladies Musculaires acquises
et
Dysimmunitaires(GERMMAD),
«
La myofasciite à macrophages. »
Presse
Med.2000 Feb 5 ;29
(4) : 203-208.
Service
de Médecine interne, Groupe Hospitalier Pitié-Salpêtrière,
Paris.
169-GHERARDI
R.K. , COQUET M. , CHERIN P. , BELEC L. , MORETTO P. ,
DREYFUS
P.A., PELLISSIER J.F. , CHARIOT P. , AUTHIER F.J. ,
«
Macrophagic myofasciitis lesions assess long-term persistence of vaccine-derived
aluminium hydroxide in muscle. »
Brain2001
Sep ;124 (Pt9) : 1821-1831.
Equipe
mixte INSERM E 0011/Université Paris XII, France.
170-Organisation
mondiale de la Santé, Genève
«
Myofasciite à macrophages et vaccins contenant de l’aluminium. »
Relevé
épidémiologique hebdomadaire n°41,15
oct 1999 ;74 : 338-340.
171-GHERARDI
R.K. , AUTHIER F.J. ,
«
Aluminum inclusion macrophagic myofasciitis ; a recently identified condition.
»
Immunol.Allergy
Clin.North Am.2003 Nov ;23
(4) : 699-712.
Muscle
and Nerve Group, Henri Mondor University Hospital, Creteil, France.
172-RIMANIOL
A.C. , GRAS G. , VERDIER F. , CAPEL F. , GRIGORIEV V.B. ,
PORCHERAY
F. , SAUZEAT E. , FOURNIER J.G. , CLAYETTE P. , SIEGRIST C.A. , DORMONT
D. ,
«
Aluminum hydroxyde adjuvant induces macrophage differentiation toward a
specialized antigen-presenting cell type. »
Vaccine2004
Aug 13 ; 22 (23-24) : 3127-3135.
SPI-BIO,
c/o Service de Neurovirologie, 92265 Fontenay-aux-Roses Cedex, France.
173-
CHERIN P. , AUTHIER F.J. , GHERARDI R.K. , ROMERO N. , LAFORET P. ,
EYMARD
B. , HERSON S. , CAILLAT-VIGNERON N. ,
«
Gallium-67 scintigraphy in macrophagic myofasciitis ».
Arthitis
Rheum.2000 Jul ;43
(7) : 1520-1526.
Groupe
Hospitalier Pitié-Salpêtrière, Paris, France.
174-MIKOL
J. , POLIVKA M. ,
«
Anatomo-pathologie des maladies musculaires inflammatoires. »
Ann.Med.Interne
(Paris)2001 Nov ;152
(7) : 465-479.
Service
Central d’Anatomie et de Cytologie Pathologiques, Hôpital Lariboisière,
2, rue Ambroise-Paré, 75475 Paris Cedex 10, France.
175-MASTAGLIA
F.L. , GARLEPP M.J. , PHILLIPS B.A., ZILKO P.J. ,
«
Inflammatory myopathies : clinical, diagnostic and therapeutic aspects.é
Muscle
Nerve2003 Apr ;27
(4) : 407-425.
Centre
for Neuromuscular and neurological Disorders, University of Western Australia,
Queen Elizabeth II Medical Centre, Nedlands, Australia.
176-CHERIN
P. , GHERARDI R.K. ,
«
Macrophagic myofasciitis. »
Curr.Rheumatol.Rep.2000
Jun ;2 (3) : 196-200.
Service
de Médecine Interne, CHU Pitié-Salpetrière, 47 Bd
de l’hôpital, 75013 Paris, France.
177-VINCENT
D. , GUILLEVIN L. , LEVESQUE M. , AUTHIER F. , VADROT D. ,
PRADALIER
A. , CHERIN P. ,
«
Association of macrophagic myofasciitis and fibromuscular dysplasia with
renal fibromuscular dysplasia : first case report. »
Clin.Exp.Rheumatol.2000
Nov-Dec ;18 (6) : 753-754.
Departement
de Médecine Interne, Hôpital Louis Mourier, Colombes, France.
178-CHERIN
P. , MENARD D. , MOUTON P. , VIALLARD J.F. , LE HELLO C. , AUTHIER F.J.,
GHERARDI
R.K. , COQUET M. , HERSON S. LEROI J.P. ,
«
Macrophagic myofasciitis associated with inclusion body myositis : a report
of three cases. »
Neuromuscul.Disord.2001
Jul ;11 (5) : 452-457.
Médecine
Interne I, CHU Pitié-Salpêtrière, 47 Bd de l’hôpital,
75013 Paris, France.
179-BONNEFONT-ROUSSELOT
D. , CHANTALAT-AUGER C. , TEIXEIRA A. ,
JAUDON
M.C. , PELLETIER S. , CHERIN P. ,
«
Blood oxidative stress status in patients with macrophagic myofasciitis.
»
Biomed.Pharmacother.2004
Nov ;58 (9) : 516-519.
Laboratoire
des lipides (Pavillon B. Delessert), Hôpital de la Pitié (AP-HP)
83, boulevard
de
l’Hôpital, 75651, Paris, cedex 13, France.
180-
AUTHIER F.J. , CHERIN P. , CREANGE A. , BONOTTE B. , FERRER X.,
ABDELMOUMNI
A. , RANOUX D. , PELLETIER J. , FIGARELLA-BRANGER D. ,
GRANEL
B. , MAISONOBE T. , COQUET M. , DEGOS J.D. , GHERARDI R.K. ,
«
Central nervous system disease in patients with macrophagic myofasciitis.
»
Brain2001
May ;124 (Pt 5) : 974-983.
Goupe
d’Etudes et de Recherches sur le Muscle et le Nerf (GERMEN, EA Université
Paris XII-Val de Marne), Faculté de Médecine de Créteil,
Département de Pathologie, Hôpital Henri Mondor, AP-HP, Créteil,
France.
181-GHERARDI
R.K. ,
«
Myofasciite à macrophages et hydroxyde d’aluminium : vers la définition
d’un syndrome
des
adjuvants. »
Rev.Neurol.
(Paris)2003 Feb. ;159
(2) : 162-164.
Groupe
Nerf-Muscle, Département de Pathologie, Hôpital Henri Mondor,
Créteil, France.
182-
BRENNER A.,
«
Macrophagic myofasciitis : a summary of Dr. Gherardi’s presentations. »
Vaccine2002
may 31 ;20 Suppl. 3 : 5-6.
Rheumatological
Services, Inc., Framington, MA 01702, USA.
183-FISHER
D. , REIMANN J., SCHRODER R.,
«
Makrophagische Myofasziitis. Eine Impfungs-assoziierte entzündliche
Muskelerkrankung. »
Dtsch.Med.Wochenschr.2003
Oct 31 ;128 (44) : 2305-2308.
Neurologische
Klinik und Poliklinik, Rheinische-Wilhelms-Universitat Bonn.
184-BORNEMANN
A. , BOHL J. , SCHNEIDER H.M. , GOEBEL H.H., SCHMIDT P.F. ,
GHERARDI
R.K.,
«
July 2003 : 62-year-old female with progressive muscular weakness. »
Brain
Pathol.2004 Jan ;14
(1) : 109-110, 115.
Institute
of Brain Research, Eberhard-Karls University, Tubingen, Germany.
185-LACSON
A.G., D’CRUZ C.A., GILBERT-BARNESS E. , SHARER L.,
JACINTO
S., CUENCA R.,
«
Aluminum phagocytosis in quadriceps muscle following vaccination in children
: relationship to macrophagic myofasciitis. »
Pediatr.Dev.Pathol.2002
Mar-Apr ;5 (2) : 151-158.
Departments
of Pediatrics and Pathology, University of South Florida at All Children’s
Hospital, 801 Sixth Street South 7020, St Petersburg, FL 33731 USA.
186-DI
MUZIO A., CAPASSO M. , VERROTTI A. , TROTTA D. , LUPO S. ,
PAPPALEPORE
N., MANZOLI C. , CHIARELLI F. , UNCINI A. ,
«
Macrophagic myofasciitis : an infantile Italian case. »
Neuromuscul
Disord.2004 Feb ;14
(2) : 175-177.
Center
for Neuromuscular Diseases, University ‘G.d’Annunzio’, Chieti, Italy.
187-NEVO
Y. , KUTAI M. , JOSSIPHOV J. , LIVNE A. , NEEMAN Z., ARAB T. ,
POPOVITZ-BIRO
R. , ATSMON J. , SHAPIRA Y. , SOFFER D. ,
«
Childhood macrophagic myofasciitis-consanguinity and clinicopathological
features. »
Neuromuscul.Disord.2004
Apr ;14 (4) : 246-252.
The
Institute for Child Development and Pediatric Neurology Unit, Tel Aviv
Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University,
Beit Habriut Strauss, 14 Balfour Street, Tel Aviv 65211, Israël.
188-NAGORE
E. , MARTINEZ-ESCRIBANO J.A. , TATO A. , SABATER V. , VILATA J.J. ,
«
Subcutaneous nodules following treatment with aluminium-containing allergen
extracts.
»
Eur.J.Dermatol.2001
Mar-Apr ;11 (2) : 138-140.
Department
of Dermatology, Hospital General Universitario, C/Denia, 20-6a,
46006
Valencia, Spain.
189-FORRESTER
T.M. , YOKEL R.A. ,
«
Comparative toxicity of intracerebroventricular and subcutaneous aluminum
in
therabbit.
»
Neurotoxicology.1985
Fall ;6 (3) : 71-80.
190-Organisation
mondiale de la Santé, Genève
«Sécurité
des vaccins. »
Relevé
épidémiologique hebdomadaire n°41,15
oct 1999 ;74 : 338-339.
191-PIYASIRISILP
S. , HEMACHUDHA T. ,
«
Neurological adverse events associated with vaccination.
Curr.Opin.Neurol.2002
Jun ;15 (3) : 333-338.
Division
of Neurology, Department of Medicine, Chiang Mai University, Chiang Mai
50200,
Thailand.
192-Organisation
mondiale de la Santé,
«
Comité consultatif mondial de la sécurité vaccinale,
10,11 juin 2004 : Sécurité des adjuvants. »
Relevé
épidémiologique hebdomadaireNum.29,16
Juillet 2004 ; 79 : 269-270.
193-MALAKOFF
D. ,
«
Public health. Aluminum is put on trial as a vaccine booster. »
Science2000
May 26 ;288 (5470 ) : 1323-1324.
194-HERNAN
M.A. , JICK S.S. , OLEK M.J. , JICK H. ,
«
Recombinant hepatitis B vaccine and the risk of multiple sclerosis : a
prospective study. »
Neurology2004
Sep 14 ;63 (5) : 838-842.
Department
of Epidemiology, Harvard School of Public Health, 677 Huntington Avenue,
Boston, MA 02115, USA.
195-Organisation
mondiale de la Santé,
«
Comité consultatif mondial sur la sécurité des vaccins
de l’Organisation mondiale de la Santé : réponse à
l’article de Hernan et al. intitulé « Vaccin Hépatite
B recombinant et risque de sclérose en plaques » publié
le 14 septembre 2004 dans la revue Neurology. »
GACVSSep
2004.
196-
VERDIER F. , BARROW P.C. , BURGE J. ,
«
Reproductive toxicity testing of vaccines. »
Toxicology2003
Apr 1 ; 185 (3) : 213-219.
Aventis
Pasteur, Campus Merieux, 1541 avenue Marcel Mérieux, 69280 Marcy
l’Etoile,
France.
197-VERDIER
F. ,
«
Non-clinical vaccine safety assessment. »
Toxicology2002
May 15;174
(1) : 37-43.
Aventis
Pasteur, Campus Merieux, 1541 avenue Marcel Mérieux, 69280 Marcy
l’Etoile,
France.
VACCINATIONS
- DECEPTION & TRAGEDY
"At the present time there are growing public and professional concerns
about the safety of currently mandated childhood vaccine programs, as reflected
in by a series of annual Congressional hearings in Washington DC that have
taken place since 1999, sponsored by the U.S. House Government Reform Committee
under the chairmanship of Congressman Dan Burton. At an annual conference
of the
Excerpt
from
The
Verge of Vaccine Mania
By Nicholas Regush
These days, children can get as many as 21 vaccines before they start the first grade, and there are about 200 more vaccines in the pipeline.
" Why are there no studies on the long-term effects of vaccination?
Why are there so few studies that have examined what happens in the body
at a cellular/molecular level after vaccination? Why are we vaccinating
children in a vacuum of scientific knowledge? Why are there no long-term
studies to assess illness and deaths related to vaccination? These are
the kind of fundamental questions that anyone involved in vaccine policy
should be addressing, but that is hardly the case. People like Fisher are
badly needed on TV and radio news programs and in newspaper stories to
raise these questions again and again — until the academics wake up and
do some real research. These days, children can get as many as 21 vaccines
before they start first grade. 
There
are about 200 more vaccines in the pipeline. Scenarios for the future even
include consuming vaccines in nose sprays, ointments and fruits and vegetables.
I call it vaccine mania. It has gone beyond what anyone can possibly defend
on scientific grounds. Pumping more vaccines into the body without understanding
such basics as how they’ll affect immune system function over time borders
on the criminal. "Read more
"Pumping more vaccines into the body without understanding such basics as how they’ll affect immunesystem function over time borders on the criminal."Nicholas Regush
Vaccine
Reaction Photos from the CDC Warning: these
are horrific photos of severe vaccine reactions in babies, children, and
adults. Photos from the Center for
Disease Control (CDC) 1
- 2
- 3
and
much more...
|
 Natural
Health for Women:
|
Natural Health: Men's Sexual Functions:
|
|
Peter R. Breggin,
M.D - "The
drugging of children has gotten so out of hand that Julian Whitaker
M.D - "Class
action lawsuits have been filed in |
|
Holistic Health Care for People & Animals
ShirleysWellnessCafe.com